LCM Capital Management’s Eli Lilly LLY Stock Holding History

LCM Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$293K	Buy	253 +8	+3%	+$9.44K	0.12%	86
2026 Q2	$294K	Buy	245 +27	+12%	+$27.6K	0.13%	87
2026 Q1	$201K	Buy	218 +10	+5%	+$10.1K	0.1%	102
2025 Q4	$224K	Buy	+208	New	+$199K	0.11%	95
2025 Q3	–	Sell	-448	Closed	-$349K	–	112
2025 Q2	$349K	Buy	448 +1	+0.2%	+$777	0.18%	71
2025 Q1	$369K	Buy	447 +30	+7%	+$25K	0.22%	63
2024 Q4	$322K	Buy	+417	New	+$345K	0.18%	68

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

LCM Capital Management's LLY Position: Q3 2026 in Review

LCM Capital Management increased its Eli Lilly (LLY) stake by 3.3% in Q3 2026, buying an estimated $9.44K and bringing the position to 253 shares worth $293K. The position accounts for 0.12% of the portfolio, ranked #86.

LCM Capital Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $369K in Q1 2025. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

LCM Capital Management held 253 shares of Eli Lilly worth $293K as of Q3 2026.
LCM Capital Management bought 8 Eli Lilly shares in Q3 2026, an estimated $9.44K.
Eli Lilly made up 0.12% of LCM Capital Management's portfolio in Q3 2026, its #86 holding.
LCM Capital Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
LCM Capital Management's Eli Lilly position peaked at $369K in Q1 2025.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on LCM Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.